References of 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-
naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-
indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,
14,17-pentazacycloicosane-4-carboxamide
Title: Lanreotide
CAS Registry Number: 108736-35-2
CAS Name: 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2?7)-disulfide
Synonyms: angiopeptin
Manufacturers' Codes: DC 13-116; BIM-23014
Molecular Formula: C54H69N11O10S2
Molecular Weight: 1096.32
Percent Composition: C 59.16%, H 6.34%, N 14.05%, O 14.59%, S 5.85%
Literature References: Octapeptide somatostatin analog. Prepn: D. H. Coy
et al., EP 215171;
eidem, US 4853371 (1987, 1989 both to Tulane Educational Fund). Clinical pharmacokinetics and hormonal effects: J. M. Kuhn
et al., Br. J. Clin. Pharmacol. 38, 213 (1994). Clinical evaluation in acromegaly: P. Caron
et al., Eur. J. Endocrinol. 132, 320 (1995).
Derivative Type: Acetate
CAS Registry Number: 127984-74-1
Manufacturers' Codes: BIM-23014C
Trademarks: Somatuline LP (Ipsen)
Line Formula: C54H69N11O10S2.xC2H4O2
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic (Hormonal); Somatostatin Analog; Somatostatin Analog.